Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse. - Wikidata - awgldk - TriplyDB

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

http://www.wikidata.org/entity/Q46781520

about

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies.Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study.26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice.The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.Hepatocarcinogenic susceptibility of fenofibrate and its possible mechanism of carcinogenicity in a two-stage hepatocarcinogenesis model of rasH2 mice.Investigations of clofibrate in alternative carcinogenicity models.Evaluation of the carcinogenic potential of clofibrate in the p53+/- mouse.Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after oral administration--part I.Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.Clofibrate in Neonatal Hyperbilirubinemia.

P2860

Q34463834-43A44B18-74DB-4251-9E8A-C82DF6199396 Q35857112-9474B193-315D-4009-B596-98F9E57AA0CB Q38061184-088FBD08-8185-466F-98BC-F115647C8D24 Q38158164-3420D0E1-C0AA-4469-AE27-27479D45CE30 Q43112569-7A05A0B6-6177-4BF1-BE2E-1C3CEBE197B4 Q46249387-691B5915-F377-46A5-A0A3-C1C5CE3DBE8B Q46269041-D0AFC173-A8D8-4303-8069-9B3B7E9B7D88 Q46781510-62EEBE18-D6BD-4608-B7EE-E8ACD91093DE Q46781515-0C3D3630-E81A-4ADE-A3EF-028FA5BB417F Q46781523-D274A6B0-5E8F-4963-AAE1-B8CC9529B33E Q46781526-9D6BC54A-AFDF-4266-A6ED-BAE0EEDB3FEC Q48287554-38B84195-F9CA-4223-911B-0757DB20321D

P2860

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

http://www.wikidata.org/entity/Q46781520

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

@en

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

@nl

type

label

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

@en

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

@nl

prefLabel

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

@en

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

@nl

P1433

Q46781520-4B703C99-91EE-4E13-9827-140AE13B4591

P1476

Q46781520-A9C12F6A-F9B9-4AF6-B29A-B35DE499B20B

P2093

Q46781520-22E87D1F-BE8D-4301-A335-126FE296F0BE

Q46781520-4E847267-7B20-453B-8CD7-2E7487BCDC62

Q46781520-5C23C494-5AAC-406E-8624-373B42AB33FE

Q46781520-86A67175-8B4D-48BE-8E97-621289877EB0

Q46781520-C32A7DF8-EA0F-40E2-93E3-396C1DDEDC78

Q46781520-F0AF7576-58CC-4D4F-ACED-D8C841829604

Q46781520-F14FD866-B236-4D8B-8A53-BDE54C52FC41

P2860

Q46781520-0962214E-2020-48BC-91AE-8ADE4B9CB3DC

Q46781520-0BB4FA62-B67C-4220-8742-1682999CC8F4

Q46781520-147D1D58-D64B-4E45-B3D0-A4D42A3F0D03

Q46781520-5074D255-B2C8-46B3-A746-EB7E37A5A960

Q46781520-608CFFAC-88B8-4FB6-8218-F8A2149DE51F

Q46781520-68A1BE94-D794-4CF2-A9F4-58B12EFA8761

Q46781520-75A94EB9-DA3B-439D-9FEC-16B1980F6DA7

Q46781520-82C92EB2-558C-4A8D-A009-F603F3BBDA53

Q46781520-8A203ED8-AE59-463D-9794-579AE0E867CE

Q46781520-8C41F3CC-E35B-469F-A341-382B67689AE5

P304

Q46781520-465C63AC-8564-4AB4-A9AA-0AAC71756343

P31

Q46781520-ED693160-5BCD-4D08-8F14-BA03A0FA12EC

P356

Q46781520-6DAD36C9-CD52-4C80-9181-081C8F2EED73

P433

Q46781520-A707CA41-8B57-4CC8-92C7-3D5484FE23AB

P478

Q46781520-8D03E130-28BF-49D6-B902-55CA08E648CE

P577

Q46781520-AF613CA6-4CED-4455-8A05-371AFFD1C39E

P698

Q46781520-049E269A-6B61-4CE8-9628-AEA5A3C074CA

P356

10915810500210278

P1433

International Journal of Toxicology

P1476

Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

@en

P2093

Christopher J Clarke

http://www.w3.org/2001/XMLSchema#string

Debie J Hoivik

http://www.w3.org/2001/XMLSchema#string

Jane S Allen

http://www.w3.org/2001/XMLSchema#string

Krzysztof Selinger

http://www.w3.org/2001/XMLSchema#string

Michael J Santostefano

http://www.w3.org/2001/XMLSchema#string

Richard T Miller

http://www.w3.org/2001/XMLSchema#string

Sarah R Nesfield

http://www.w3.org/2001/XMLSchema#string

P2860

The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model

The cytochrome P450 4 (CYP4) family

P53+/- hemizygous knockout mouse: overview of available data.

Thiazolidinediones.

Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute.

The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models.

PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.

P304

301-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10915810500210278

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16257850

http://www.w3.org/2001/XMLSchema#string